“…However, the reported results on such measurements lack agreement (Newcomb & DeVald, 1969;Ryley and Brogan, 1968;Brogan et al, 1971;Heilpern & Rebuck, 1972;Smith, Bellanti & Chanock, 1967;Ishizaka & Newcomb, 1970;Hobday, Cake & Turner, 1971). Disodium cromoglycate (DSCG), with few exceptions, affords 'protective' effects in asthma, and apparently reduces the incidence of coughing and the secretion of bronchial mucus (Holmgren et al, 1972). Heilpern & Rebuck (1972) reported that the albumin content was significantly higher in the sputum of asthmatic patients than in non-asthmatics, and that DSCG therapy reduced the level of sputum albumin in the asthmatics to that found in the control non-asthmatic subjects.…”